Authors
Luca Errichiello, Marianna Pezzella, Lia Santulli, Salvatore Striano, Federico Zara, Carlo Minetti, Paolo Mainardi, Pasquale Striano
Publication date
2011/12
Journal
Movement disorders
Volume
26
Issue
14
Pages
2573-2575
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Description
Results
All the subjects completed the trial. None of patients experienced subjective change of myoclonus. Six individuals were randomized to receive placebo (Suppl. Table 1). No serious adverse events were recorded. Two subjects on ALAC (15.3%) and 1 subject on placebo (7.6%) reported mild drowsiness.
Total citations
2012201320142015201620172018201920202021202222111251
Scholar articles